The DCT OS Report: More than 95% of biopharma executives say we're not going back to a site-based-only development model. Learn more

News.

Science 37 related announcements, media, stories, and more.

Rapid-Start COVID-19 Studies Delivered through Science 37<sup>®</sup> and Innovo Partnership
Rapid-Start COVID-19 Studies Delivered through Science 37® and Innovo Partnership

Rapid-Start COVID-19 Studies Delivered through Science 37 and Innovo Partnership   The new partnership will help accelerate the start-up time for clinical trials related to the COVID-19 pandem...

CONTINUE
Navigating Clinical Trials in the Coronavirus Era
Navigating Clinical Trials in the Coronavirus Era

The report explores approaches for sponsors to mitigate risks to patient safety and business continuity in clinical trials - both immediately and moving forward.   LOS ANGELES, March 12, 2020 ...

CONTINUE
Science 37<sup>®</sup> Strengthens Operational Efficiencies with EDC Integration
Science 37® Strengthens Operational Efficiencies with EDC Integration

The fully integrated mobile enhancement provides a real-time window into trial operations -- LOS ANGELES, February 18, 2020 - Science 37, the industry leader in decentralized clinical trials, has l...

CONTINUE
Science 37<sup>®</sup> Enhances Its Patient Experience and Introduces Native Support for iOS and Android
Science 37® Enhances Its Patient Experience and Introduces Native Support for iOS and Android

The fully integrated mobile enhancement provides a real-time window into trial operations† LOS ANGELES, February 18, 2020 Science 37, the industry leader in decentralized clinical trials, ha...

CONTINUE
Science 37<sup>®</sup> Extends Market-Leading Capabilities in Decentralized Clinical Trial Execution
Science 37® Extends Market-Leading Capabilities in Decentralized Clinical Trial Execution

New additions to the Science 37 executive team will enhance both the patient and sponsor experiences as well as extend patient recruitment and trial execution efficiencies -- LOS ANGELES, January 1...

CONTINUE
Science 37<sup>®</sup> Appoints Steven Geffon as Chief Commercial Officer
Science 37® Appoints Steven Geffon as Chief Commercial Officer

Executive role will significantly scale commercial operations and create unparalleled value for clients -- LOS ANGELES, December 17, 2019 - Science 37, the industry leader in decentralized clinical...

CONTINUE
Science 37<sup>®</sup> Names David Coman Chief Executive Officer
Science 37® Names David Coman Chief Executive Officer

Organization extends its market leadership in the decentralized clinical trial industry LOS ANGELES, November 21, 2019 - Science 37, the industry leader in decentralized clinical trials, announced ...

CONTINUE
Keck School of Medicine of USC and Science 37<sup>®</sup> Collaborate on Largest Ever NIH-Funded, Telemedicine-Based Dermatology Study
Keck School of Medicine of USC and Science 37® Collaborate on Largest Ever NIH-Funded, Telemedicine-Based Dermatology Study

The two organizations will compare care methods for treating patients with eczema LOS ANGELES, October 1, 2019 -- Science 37, the industry leader in virtual clinical trials, and the Keck School of ...

CONTINUE
Science 37<sup>®</sup> Raises $35M in Funding to Continue to Drive Growth - Announces Leadership Transition
Science 37® Raises $35M in Funding to Continue to Drive Growth - Announces Leadership Transition

PLAYA VISTA, Calif – Science 37, a patient-centric clinical trial company, announced today that it has raised $35 million in Series D financing led by Pharmaceutical Product Development, LLC ...

CONTINUE
Science 37<sup>®</sup> and Boehringer Ingelheim Initiate a Collaborative Partnership to Accelerate Patient Centricity in the Development of Novel Therapies
Science 37® and Boehringer Ingelheim Initiate a Collaborative Partnership to Accelerate Patient Centricity in the Development of Novel Therapies

Ingelheim, Germany and Playa Vista, CA, USA , January 3, 2019 - Science 37, an industry leader in virtual clinical trials, and Boehringer Ingelheim announced today a technology enterprise collabora...

CONTINUE
Page 3 of 3
123